ESCRS - PP01.05 - IN VIVO CONFOCAL MICROSCOPY EVALUATION OF INFILTRATED IMMUNE CELLS IN CORNEAL STROMA TREATED WITH CELL THERAPY IN ADVANCED KERATOCONUS

IN VIVO CONFOCAL MICROSCOPY EVALUATION OF INFILTRATED IMMUNE CELLS IN CORNEAL STROMA TREATED WITH CELL THERAPY IN ADVANCED KERATOCONUS

Published 2025 - 29th ESCRS Winter Meeting

Reference: PP01.05 | Type: Free Paper | DOI: 10.82333/96v1-ke56

Authors: Mona El Zarif* 1 , Karim Abdul Jawad 2 , Nehman Makdissy 3

1Division of Ophthalmology,Universidad Miguel Hernández,Elche,Spain;Department of research in ophthalmology and optometry,Optica General,Saida,Lebanon;Doctoral School of Sciences and Technology,Lebanese University ,Hadath,Lebanon, 2Department of research in ophthalmology and optometry,Optica General,Saida,Lebanon, 3Genomic Surveillance and Biotherapy GSBT, Faculty of Sciences,Lebanese University ,RasMaska,Lebanon

Purpose

This study investigates immune cell (ICs) infiltration in advanced keratoconus patients undergoing autologous adipose-derived adult stem cell (ADASC) therapy with recellularized human donor corneal laminas (CL).

Setting

Division of Ophthalmology, Universidad Miguel Hernández, Alicante, Spain. Lebanese University, Doctoral School of Sciences and Technology, Lebanon.Lebanese University, Genomic Surveillance and Biotherapy GSBT, Faculty of Sciences, RasMaska, Lebanon.Optica General, Saida,  Lebanon.

Methods

A prospective clinical trial included fourteen patients divided into three groups: G-1, ADASCs; G-2, decellularized CL (dCL); and G-3, dCL recellularized with ADASCs (ADASCs-rCL). Infiltrated ICs were assessed using in vivo confocal microscopy (IVCM) at 1,3,6, and 12 months post-transplant.

Results

Infiltrated ICs, encompassing granulocytes and agranulocytes, were observed across all groups, categorized by luminosity, structure, and area. Stromal ICs infiltration ranged from 1.19% to 6.62%, with a consistent increase in group-related cell density (F=10.68, P<.0001), independent of post-op time (F=0.77, P=0.511); the most substantial variations were observed in G-3 at 6 and 12 months (2.0 and 1.87-fold, respectively). Similarly, significant size increases were more group-dependent (F=5.76, P<.005) rather than time-dependent (F=2.84, P<.05); G-3 exhibited significant increases at 6 and 12months (3.70-fold and 2.52-fold, respectively). A lamina-induced shift in IC size occurred (F=110.23, P<.0001), primarily with 50-100 μm² sizes and up to larger cells >300μm², presumably macrophages, notably in G-3, indicating a potential role in tissue repair and remodeling, explaining reductions in cells remnants <50μm².

Conclusion

ADASCs-rCL therapy may lead to increased IC infiltration compared to ADASCs alone, impacting cell distribution and size due to the presence of the lamina. The findings reveal intricate immune patterns shaped by the corneal microenvironment and highlight the importance of understanding immune responses for the development of future therapeutic strategies.